Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | Perceptive Advisors LLC | 1,800,000 3.600% | -350,641 (-16.30%) | Filing History |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Perceptive Advisors LLC | 1,212,694 2.600% | -1,960,091 (-61.78%) | Filing History |
| 2023-02-14 2:33 pm Purchase | 2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Perceptive Advisors LLC | 6,088,333 9.200% | 3,116,920 (+104.90%) | Filing History |
| 2023-02-14 2:33 pm Unchanged | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Perceptive Advisors LLC | 1,296,416 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:33 pm Sale | 2022-12-31 | 13G | IsoPlexis Corporation ISO | Perceptive Advisors LLC | 4,095,498 10.000% | -780,032 (-16.00%) | Filing History |
| 2023-02-14 2:33 pm Unchanged | 2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Perceptive Advisors LLC | 3,007,858 14.400% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:33 pm Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | Perceptive Advisors LLC | 587,400 0.400% | -5,892,600 (-90.94%) | Filing History |
| 2023-02-14 2:33 pm Purchase | 2022-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | Perceptive Advisors LLC | 11,350,085 19.400% | 1,446,206 (+14.60%) | Filing History |
| 2023-02-14 2:32 pm Sale | 2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 9,971,780 6.300% | -156,161 (-1.54%) | Filing History |
| 2023-02-14 2:32 pm Purchase | 2022-12-31 | 13G | BELLUS Health Inc. BLU | Perceptive Advisors LLC | 8,891,027 7.100% | 1,245,793 (+16.30%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Zymeworks Inc. ZYME | Perceptive Advisors LLC | 4,511,275 7.200% | 4,511,275 (New Position) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 937,515 9.900% | -16,733 (-1.75%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 27,642,917 9.800% | 286,874 (+1.05%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 224,869 5.300% | -141,076 (-38.55%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Arcellx, Inc. ACLX | Perceptive Advisors LLC | 2,598,305 5.500% | 2,598,305 (New Position) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 11,900,255 5.400% | -33,132 (-0.28%) | Filing History |
| 2023-02-14 2:31 pm Unchanged | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Perceptive Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | Perceptive Advisors LLC | 1,757,160 8.500% | -602,979 (-25.55%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Veru Inc. VERU | Perceptive Advisors LLC | 785,801 9.700% | 785,801 (New Position) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Perceptive Advisors LLC | 2,617,691 4.200% | -2,232,221 (-46.03%) | Filing History |